Skip to content

Study of CO2 fractional laser therapy combined with 30% salicylic acid on atrophic acne scars

Study of CO2 fractional laser therapy combined with 30% salicylic acid on atrophic acne scars

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500095871
Enrollment
Unknown
Registered
2025-01-14
Start date
2025-01-31
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrophic acne scars

Interventions

Interventions group:Immediately after the end of laser treatment, one side was randomly selected to be treated with 30% SSA (S group) (BRODA, Shanghai Ruishi Medical Technology Co., Ltd., China). Dilu

Sponsors

Wuxi No 2 People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Patients with acne atrophic scars on both sides of the face, aged 18 to 45, gender unspecified.

Exclusion criteria

Exclusion criteria: Patients who are pregnant or breastfeeding, have a history of lidocaine or SSA allergies, suffer from keloids, diabetes, malignant tumors, use glucocorticoids, anticoagulants, or immunosuppressants as well as those who had laser and other treatments done in the previous 6 months will be excluded from the study

Design outcomes

Primary

MeasureTime frame
échelle d'évaluation clinique des cicatrices d'acné score;

Secondary

MeasureTime frame
Time for swelling to subside;Immediate postoperative observation; The level of pores;The skin texture; The erythema value and the melanin value;Sebum level;Numeric Rating Scale score;

Countries

china

Contacts

Public Contacttaoshiqin

Wuxi No 2 People’s Hospital

18761659301@163.com+86 139 1532 1981

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026